BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11857499)

  • 1. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
    Baeten D; Demetter P; Cuvelier CA; Kruithof E; Van Damme N; De Vos M; Veys EM; De Keyser F
    J Pathol; 2002 Mar; 196(3):343-50. PubMed ID: 11857499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
    Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
    Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
    Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.
    Kruithof E; De Rycke L; Vandooren B; De Keyser F; FitzGerald O; McInnes I; Tak PP; Bresnihan B; Veys EM; Baeten D;
    Arthritis Rheum; 2006 Jun; 54(6):1795-804. PubMed ID: 16729282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
    Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
    Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis.
    De Rycke L; Baeten D; Foell D; Kruithof E; Veys EM; Roth J; De Keyser F
    J Pathol; 2005 May; 206(1):17-27. PubMed ID: 15809977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA; Radstake TR; Lubberts E; van den Bersselaar LA; van Riel PL; van Lent PL; Barrera P; van den Berg WB
    Arthritis Rheum; 2003 Feb; 48(2):339-47. PubMed ID: 12571842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
    Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
    Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
    Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis.
    Kruithof E; Van den Bossche V; De Rycke L; Vandooren B; Joos R; Cañete JD; Tak PP; Boots AM; Veys EM; Baeten D
    Arthritis Rheum; 2006 Aug; 54(8):2594-604. PubMed ID: 16868982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.
    van Lent PL; Figdor CG; Barrera P; van Ginkel K; Slöetjes A; van den Berg WB; Torensma R
    Arthritis Rheum; 2003 Feb; 48(2):360-9. PubMed ID: 12571844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.
    Fonseca JE; Edwards JC; Blades S; Goulding NJ
    Arthritis Rheum; 2002 May; 46(5):1210-6. PubMed ID: 12115225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.
    Baeten D; Kruithof E; Van den Bosch F; Demetter P; Van Damme N; Cuvelier C; De Vos M; Mielants H; Veys EM; De Keyser F
    Arthritis Rheum; 2001 Jan; 44(1):186-95. PubMed ID: 11212159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis.
    Demetter P; Van Huysse JA; De Keyser F; Van Damme N; Verbruggen G; Mielants H; De Vos M; Veys EM; Cuvelier CA
    J Pathol; 2002 Dec; 198(4):517-22. PubMed ID: 12434422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
    Kunisch E; Fuhrmann R; Roth A; Winter R; Lungershausen W; Kinne RW
    Ann Rheum Dis; 2004 Jul; 63(7):774-84. PubMed ID: 15194571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.